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The pattern of valvular heart disease is changing in 
Western populations [1]. There are implications for Africa 
as healthcare improves and people live longer. 
Over the last half century in Western countries there 
has been a change in the incidence of valvular heart disease 
from a rheumatic cause to one of degeneration. Until 
the age of 64 years all moderate to severe valve disease 
affects less than 2%. In the group aged 64 – 75 years the 
proportion increases to 4 - 8% and after age 75 years it 
rises to 12 - 13%. Mitral incompetence (regurgitation) 
and aortic stenosis contribute to the majority of cases. 
Mitral stenosis is much more common in patients who 
have had rheumatic heart disease. As the population ages 
the healthcare burden of valvular heart disease will become 
greater.
Mitral incompetence is commoner than aortic 
stenosis. There are two main causes:
• The first, primary, arises from an abnormality of 
the valve. 
• The second, secondary, follows an abnormality of 
the left ventricle.
In primary mitral incompetence the valve leaflets 
do not come together adequately at the time of systolic 
contraction of the left ventricle. The result is that some 
of the blood that should have been pumped out (i.e. a 
proportion of the stroke volume) is regurgitated into 
the left atrium. In severe cases this regurgitant volume 
may exceed 50% of the stroke volume. The left atrium 
then dilates. The left ventricle compensates by dilating 
to increase stroke volume following Starling’s law of the 
heart. Initially no clinical symptoms may appear but 
eventually the left ventricle fails.
There are various forms of primary mitral 
incompetence:
• “Degenerative”: this may lead to thickening 
or thinning of the valve leaflets. If the chordae 
tendinae lengthen or rupture then the leaflets 
prolapse into the left atrium.
• Bacterial endocarditis.
• Rheumatic cause is much less common than in 
developing countries.
• Congenital abnormalities of the valve.
• Drugs e.g. pergolide and carbergoline as used in 
Parkinson’s disease [2].
The progression of primary mitral incompetence 
varies. About 50% of patients come to no harm. However 
at the opposite extreme about 20% develop heart failure. 
If the incompetence is severe when first diagnosed then 
the outlook is much worse. Also if the cause is a ruptured 
of chorda tendinae the prognosis is also poor.
Myocardial infarction or a cardiomyopathy leading 
to left ventricular dilatation or hypertrophy may cause a 
dilatation of the mitral ring  and hence secondary mitral 
incompetence. The valve leaflets themselves remain 
normal but do not come together in systole. Ischaemic 
coronary artery disease (including myocardial infarction) 
is the commonest cause. So when the latter occurs it is on 
top of an already damaged left ventricle. About 12% of 
patients develop moderate to severe mitral incompetence 
a month after a myocardial infarction.
Aortic stenosis results from an impaired mobility of 
the valve cusps (normally three). The opening of the valve 
in left ventricular systole gradually reduces (normal 3 – 
4 cm2). Eventually the rising pressure gradient across the 
valve leads to extra work for the left ventricle. The ventricle 
compensates by increasing the muscular wall thickness 
(hypertrophy). Exertional breathlessness indicates failure 
of the left ventricle.
There are three main causes of aortic stenosis in 
Western countries:
• A bicuspid aortic valve is a congenital abnormality 
and is more prone to calcification.
• A normal tricuspid valve may become calcified.
• Rheumatic heart disease but this is now rare.
A number of factors predispose to thickening of the 
aortic valve (before stenosis occurs this is called sclerosis):
• Increasing age.
• Males more than females.
• Hypertension.
• Smoking.




About a quarter of people over aged 65 years have a 
degree of aortic sclerosis. Almost 10% of these develop 
aortic stenosis during the next five years. 
Aortic incompetence (regurgitation) occurs if the 
valve cusps do not come together closely in left ventricular 
diastole. The consequence is that some of the stroke 
volume flows back into the left ventricle in diastole. In 
severe cases this may reach 50% of the stroke volume 
putting extra strain on the left ventricle which then 
gradually dilates and the wall hypertrophies. For a time 
this creates a compensatory situation but eventually the 
left ventricle fails. 
The underlying causes of aortic incompetence include:
• Abnormality of the valve itself e.g. congenital
  bicuspid structure, bacterial endocarditis.
• Aortic root abnormality especially if this is
  accompanied by a dilated root as in e.g. syphilis
  or Marfans syndrome.
Mitral stenosis results from a thickening and fusion 
of the valve leaflets. The opening of the valve (normal 
4cm2) is reduced during left ventricular diastole (left 
atrial systole). The pressure in the left atrium rises and 
this chamber dilates. The lung vascular pressure rises 
(pulmonary hypertension). The patient becomes breathless 
on exercise. Wheezing may mimic bronchial asthma and 
hence suggest the wrong diagnosis. Finally in turn the 
right ventrical dilates and signs of right ventricular failure 
with pedal oedema and eventually ascites do occur.
The cause of mitral stenosis in Western populations 
is now much more likely to be a congenital abnormality 
whereas in a developing rheumatic fever remains the 
overwhelming cause.
The situation in Africa
A review of valvular heart disease (rheumatic and non-
rheumatic) in Africa [3] shows that the focus remains on 
rheumatic heart disease.
In Western nations valvular heart disease affects the 
older patient and is slow in onset. In Africa it is the young 
who tend to be affected and the disease progresses much 
more rapidly.
The Lancefield Group A streptococcus is the 
precipitating cause of acute rheumatic fever. In Western 
countries it occurs in less than 1 in 100,000 of the 
population whereas in Africa (e.g. Sudan) it is as common 
as 1 in 1,000. The reasons for this difference probably 
include:
• Household overcrowding, especially with
     increasing urbanisation, leading to closer person-
 to-person contact.
• Patterns and / effectiveness of antibiotic use.
• Virulence of the infecting streptococcus.
A review of some of the incidences of chronic rheumatic 
heart disease in school children is striking:
• Nairobi (Kenya): 2.7 in 1,000 
• Kinshasa (DRC): 14.3 in 1,000
• Soweto (South Africa) (1975): 6.9 – 20 in 1,000
• Kampala (Uganda) (2012): 14.7 in 1,000 [4] 
What happens to the heart in acute rheumatic fever 
Echocardiographic studies indicate that severe mitral 
incompetence is the result of annular (the ring structure 
at the base of the valve) dilatation and elongation of the 
chordae tendinae leading to prolapse of the valve leaflet 
back in the direction of the left atrium. Sometimes the 
systolic murmur of mitral incompetence cannot be heard 
with the stethoscope and it is then that echocardiography 
is so useful. 
Initially the valve leaflets are normal but later 
may become fibrosed and rigid adding stenosis to the 
incompetence.
This is what happens clinically in acute rheumatic 
fever:
• Streptococcal infection: usually a sore throat 
(pharyngitis).
• Up to three weeks later: fever and large joint pains 
and swelling.
• Fast heart rate (tachycardia) which seems greater 
than would be expected with the degree of fever.
• Systolic and diastolic mitral murmurs vary 
from time to time and frequent auscultation is 
mandatory.
• If pericarditis develops then a pericardial friction 
rub may be heard.
• Signs of heart failure suggest heart muscle damage.
However it must be appreciated that only about a 
quarter of patients who are found to have rheumatic 
valvular disease later in life give a clear history of rheumatic 
fever.
It is worth mentioning the importance of rheumatic 
heart disease in association with pregnancy. Where 
there is a significant rate of teenage pregnancy and a high 
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incidence of rheumatic heart disease the coincidence of 
each condition in the same patient is potentially serious. 
But which patients are at greatest risk? Mitral stenosis is 
the most common lesion, it is the most serious lesion and 
may be discovered for the first time in the antenatal clinic. 
In practice there are three main situations that may face 
the clinician and obstetrician:
• Known mitral stenosis and wishes to become 
pregnant.
• Mitral stenosis that is well compensated in a 
patient already pregnant.
• Severe mitral stenosis, a critical cardiac state (i.e. 
poor haemodynamic condition) and in advanced 
pregnancy.
The physiologically increased cardiac rate during 
pregnancy with its reduced diastolic filling time of the left 
ventricle poses the main danger for the pregnant woman 
with mitral stenosis. Wherever possible such patients 
should be referred urgently for a specialist opinion. The 
options include the use of diuretics, a beta-blocker, mitral 
valvuloplasty and valve replacement. However the surgical 
options are likely not to be available.
Non-rheumatic valvular heart disease in Africa
All of the non-rheumatic heart conditions that occur 
in Western populations may, of course, appear in African 
countries but there are a number of differences.
Bacterial endocarditis
The high prevalence of rheumatic valvular heart disease 
in Africa means that there are large numbers of patients at 
risk of bacterial endocarditis. This places a great burden 
on limited healthcare resources. Clearly efforts must be 
directed at the prevention of rheumatic valvular disease 
by prevention of the original rheumatic process caused 
by the streptococcus: namely the effective treatment of 
streptococcal infections and improved social conditions 
where such infections proliferate. 
In addition the sources of infection for the endocarditis 
must be managed. For example, by adequate dental care 
and appropriate antibiotic use especially for streptococcal 
throat infections. In the UK, National Institute for 
Health Care and Excellence guidelines [4] no longer 
advise prophylaxis. There is no clinical evidence that 
prophylactic antibiotics reduce the incidence of infective 
endocarditis. The disadvantages (e.g. allergic reactions 
and increased bacterial resistance) may be greater than 
the benefits. But does this also apply in the same way 
to African circumstances [6,7]? Antibiotic-related side 
effects do occur but are uncommon after a single dose of 
antibiotics as for prophylaxis [8,9]. The American Heart 
Association [9] considers it safe to give a single dose of a 
broad spectrum antibiotic (e.g. amoxicillin) if there is no 
history of hypersensitivity. The controversy remains (see 
Author’s note below).
Secondary prevention of rheumatic heart disease
This depends on adequate public health arrangements. 
Ideally benzathine penicillin 1.2 mega units once per 
month (or sulphadiazine 500mg twice daily) to those aged 
over 10 years and once daily to those under aged 10 years. 
The duration of this prophylaxis depends on how severe 
the original disease was and how long since the attack 
[10]. Usually the duration is taken as five years or until 
the patient is 18 years old.
Submitral Aneurysm
This condition is thought to be congenital in origin 
arising from a weakness in the mitral annulus. Most 
reports of this left ventricular aneurysm come from sub-
Saharan Africa. It causes severe mitral incompetence 
because of undermining of the valve leaflets and papillary 
muscle. Sometimes the aneurysm ruptures into the 
left atrium. Cardiac dysrhythmias are common and 
myocardial ischaemia may be caused by compression of 
the left circumflex coronary artery. The only satisfactory 
treatment is surgical. 
Finally, a quote directly from the publication by Essop 
and Nkomo [3]:
“Africa faces many difficulties, and the challenge of 
preventing and treating the scourge of rheumatic heart 
disease is enormous. If we are to rise to this challenge, we 
need to establish the scope and magnitude of the problem with 
large, properly conducted epidemiological trials, and health 
authorities must be urgently convinced of the need to institute 
efficient and readily accessible programs for the primary and 
secondary prevention of rheumatic heart disease.” 
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Author’s note: There clearly is controversy about the use 
of antibiotics to prevent bacterial endocarditis in Africa. 
This needs further research. The clinical experience of 
colleagues in South Sudan reported to this journal would 
be most valuable: Is bacterial endocarditis often seen or 
recognised? Does it appear to follow interventions such as 
dental extractions?
STARLING, Ernest Henry (1866 – 1927) was a British physiologist studying at Guy’s Hospital in London 
and later became Professor of Physiology at University College (London). He described what has become 
known as “Starling’s law of the heart”: the force of contraction of the heart muscle is proportional to its 
initial length. This means that, in for example mitral incompetence, as the left ventricle dilates and the 
muscle wall stretches the power (force) of contraction after each cycle of stretch increases. However 
eventually this “law” fails and so does the left ventricle. Another way of looking at this is to take an 
elastic band: stretch it to say 10 cms and release it and measure the distance it is projected. Then repeat 
the exercise but stretch the band to 20 cms before release: it should be projected approximately twice 
the distance. However if you then gradually increase the initial stretch further there will come a time 
when the band breaks. If you try this experiment be very careful not to flick the band into your eyes or 
someone elses!!!
SOUTH SUDAN GENERAL MEDICAL COUNCIL LAUNCHED
The South Sudan General Medical Council (SSGMC) has officially launched its services in a ceremony in 
Juba on 4 November. The launch also saw the official unveiling of its website – see http://southsudangmc.
org/. The South Sudan General Medical Council is an autonomous body responsible for the registration and 
regulation of medical, dental and pharmaceutical practices in the world’s newest country.
